Toxikon Corporation, a leading global preclinical contract research organization (CRO), has launched a new website at www.toxikon.com, targeted towards scientists, engineers, and regulatory professionals involved in developing and commercializing medical devices, pharmaceuticals, and biologic products.
“For more than 40 years, Toxikon has shown that quality science and ongoing education are key to quickly and successfully developing medical products,” said Dr. Laxman S. Desai, Chief Executive Officer and President. “We remain committed to helping our partners and clients bring novel therapies to market efficiently, and will stand by them through every step of the regulatory pathway. Our relaunched website is an important resource for prospective clients to understand the preclinical process and understand how to navigate that process efficiently.”
Toxikon’s new website features in-depth descriptions of preclinical tests and sample requirements;
“Toxikon’s distinguished scientific staff not only fully understand medical device and pharmaceutical testing requirements;